Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-01-10
1999-07-13
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514404, 514406, 514359, 514383, 514384, 514389, 5483661, 5483704, 5483714, 5483717, 5483725, 5483741, 5483761, 548255, 5482622, 5482648, 5483171, 5483185, 5483315, 5483331, 5483335, 5483431, 5483345, 5483425, 5483435, 5483461, A61K 31415, A61K 3141, A61K 3142, A61K 31425
Patent
active
059227516
ABSTRACT:
Novel compounds which are effective PDE IV inhibitors are disclosed The compounds possess similar or improved PDE IV inhibition as compared to rolipram, with improved selectivity with regard to, e.g., PDE III inhibition. Preferred compounds are 3-(3-cyclopentyloxy-4-methoxy-benzylamino)-4-hydroxymethyl pyrazole and 3-(3-cyclopentyloxy-4-methoxybenzylamino)-4-methoxymethylpyrazole.
REFERENCES:
patent: Re31429 (1983-10-01), Tull et al.
patent: 2320654 (1943-06-01), Riester
patent: 2691654 (1954-10-01), Hitchings
patent: 2844577 (1958-07-01), Acker
patent: 2903455 (1959-09-01), Strong et al.
patent: 2956998 (1960-10-01), Baizer
patent: 2957875 (1960-10-01), Lyttle et al.
patent: 2966488 (1960-12-01), Shive et al.
patent: 3079378 (1963-02-01), Schroeder
patent: 3129225 (1964-04-01), Shapiro
patent: 3135753 (1964-06-01), Hitchings
patent: 3136771 (1964-06-01), Liechti et al.
patent: 3215696 (1965-11-01), Denayer
patent: 3225046 (1965-12-01), Zwahlen
patent: 3262929 (1966-07-01), Okubu et al.
patent: 3470164 (1969-09-01), Takamatsu
patent: 3491091 (1970-01-01), Berger
patent: 3491106 (1970-01-01), Freyermuth
patent: 3494919 (1970-02-01), Collins et al.
patent: 3516997 (1970-06-01), Takano et al.
patent: 3541100 (1970-11-01), Ramirez et al.
patent: 3551554 (1970-12-01), Herschler
patent: 3574218 (1971-04-01), Hideg et al.
patent: 3586670 (1971-06-01), Brenneisen
patent: 3590029 (1971-06-01), Koch
patent: 3626018 (1971-12-01), Taylor
patent: 3636039 (1972-01-01), Gruenman et al.
patent: 3647812 (1972-03-01), Smith
patent: 3658799 (1972-04-01), Eardley
patent: 3666769 (1972-05-01), Jones
patent: 3669979 (1972-06-01), Freyermuth
patent: 3674781 (1972-07-01), Schinzel et al.
patent: 3681328 (1972-08-01), Kurita
patent: 3686238 (1972-08-01), Zaffaroni
patent: 3706834 (1972-12-01), Scheilenbaum et al.
patent: 3923833 (1975-12-01), Gruenmann et al.
patent: 3962452 (1976-06-01), Evans et al.
patent: 4020165 (1977-04-01), Hubbard
patent: 4025636 (1977-05-01), Dunwell et al.
patent: 4025637 (1977-05-01), Dunwell
patent: 4107306 (1978-08-01), Voorhees
patent: 4167628 (1979-09-01), Kormany
patent: 4233303 (1980-11-01), Bergstrand et al.
patent: 4241063 (1980-12-01), Naito et al.
patent: 4241168 (1980-12-01), Arai
patent: 4308278 (1981-12-01), Schneider et al.
patent: 4361699 (1982-11-01), Rasmusson et al.
patent: 4407802 (1983-10-01), Graham et al.
patent: 4416892 (1983-11-01), Dawson
patent: 4454138 (1984-06-01), Goring
patent: 4469698 (1984-09-01), Phillppossian et al.
patent: 4616020 (1986-10-01), Furrer et al.
patent: 4652654 (1987-03-01), Verga et al.
patent: 4684656 (1987-08-01), Atwal
patent: 4684728 (1987-08-01), Mohring
patent: 4710503 (1987-12-01), Hofer
patent: 4732978 (1988-03-01), Kreft et al.
patent: 4755517 (1988-07-01), Bruns et al.
patent: 4757124 (1988-07-01), Koyanagi
patent: 4769377 (1988-09-01), Snyder et al.
patent: 4770990 (1988-09-01), Nakamura
patent: 4803216 (1989-02-01), Appleton et al.
patent: 4810719 (1989-03-01), Appleton et al.
patent: 4826868 (1989-05-01), Wachter et al.
patent: 4831152 (1989-05-01), Itoh et al.
patent: 4851321 (1989-07-01), Takagi
patent: 4874869 (1989-10-01), Ueda et al.
patent: 4883801 (1989-11-01), Nathanson
patent: 4910211 (1990-03-01), Imamura et al.
patent: 4918074 (1990-04-01), Tsuda et al.
patent: 4925847 (1990-05-01), Hofer
patent: 4965169 (1990-10-01), Hirano
patent: 4971972 (1990-11-01), Doll et al.
patent: 4981857 (1991-01-01), Daluge
patent: 4994363 (1991-02-01), Koya et al.
patent: 5010081 (1991-04-01), Hofer
patent: 5047411 (1991-09-01), Takasugi et al.
patent: 5057517 (1991-10-01), Johnston et al.
patent: 5068236 (1991-11-01), Suzuki et al.
patent: 5091431 (1992-02-01), Tulshian et al.
patent: 5098464 (1992-03-01), Barton et al.
patent: 5110818 (1992-05-01), Allgeier
patent: 5114835 (1992-05-01), Sakaoue
patent: 5116717 (1992-05-01), Matsushita
patent: 5117830 (1992-06-01), McAfee et al.
patent: 5139921 (1992-08-01), Takagi et al.
patent: 5177074 (1993-01-01), Allen et al.
patent: 5177085 (1993-01-01), Naef
patent: 5190942 (1993-03-01), Poss
patent: 5191084 (1993-03-01), Bagli et al.
patent: 5206255 (1993-04-01), Ubasawa et al.
patent: 5264589 (1993-11-01), Corey
patent: 5270206 (1993-12-01), Saccomano
patent: 5288896 (1994-02-01), Capiris et al.
patent: 5290782 (1994-03-01), Suzuki et al.
patent: 5322847 (1994-06-01), Marfat et al.
patent: 5342835 (1994-08-01), Pepin et al.
patent: 5424432 (1995-06-01), Fredenburgh et al.
patent: 5434150 (1995-07-01), Austel et al.
patent: 5449686 (1995-09-01), Christensen, IV
patent: 5451596 (1995-09-01), Ullrich
patent: 5496853 (1996-03-01), Shiota et al.
patent: 5602157 (1997-02-01), Christensen, IV
patent: 5602173 (1997-02-01), Christensen, IV
patent: 5631260 (1997-05-01), Belardinelli et al.
Ronald E. Weishaar, et al., Subclasses of Cyclic GMP-Specific phosphodiesterase and their role in regulating the effects of atrial natriuretic factor, Dept. of Pharmacology, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co. Hypertension, vol. 15, No. 5, May, 1990, p. 528.
"Structure-Activity Relationships in a Series of 6-Thioxanthines with Bronchodilator and Coronary Dilator Properties", A.K. Armitrage, Janet Boswood and B.J. Large, Brit. J. Pharma. 1961, 17:196-207.
"The Synthesis of Some 6 Thioxanthines", K.R.H. Wooldrige and R. Slack, J. Chem. Soc., 1962, Annex IV:1863-1868.
Chemical Abstracts, vol. 85, No. 1 (Jul. 9, 1976) 5692s (Enoki).
Chemical Abstracts, vol. 84, No. 25 (Jun. 21, 1976) 180299v (Enoki).
Chemical Abstracts, vol. 86, No. 7 (Feb. 14, 1977) 43746r (Aida).
Isomura et al., "Studies on the synthesis and anti-inflammatory activity of 2,6-Di-tert-butylphenols with a heterocyclic group at the 4-position.I", vol. 31, No. 9, pp. 3168-3178 (1983).
Chemical Abstracts 103: 37354, 1985 (Nagarajan).
Chemical Abstracts 116: 255335, 1992 (Bender).
Itaya, Tetrahedron Letters, vol. 23, No. 21 (1982), pp. 2203-2204.
Reitz, Journal of Organic Chemistry, vol. 55, No. 22 (Oct. 26, 1990), pp. 5761-5766.
Chemical Abstracts 88: 51054, 1977 (Ninomiya).
Chemical Abstracts, vol. 82 (19) May 12, 1975, Abstract #125358x (Kazimierezuk).
Chemical Abstracts 114: 246982, 1990 (Naruto).
"Controlled Interaction between Nucleic Acid Bases. Intramolecular Stacking Interactions between Two Adenine Rings", Nelson J. Leonard, et al.; Journal of the American Chemical Society, 95:12, Jun. 13, 1973, pp. 4010-4016.
Chemical Abstracts 92: 6207, 1977 (Pirisino).
Ronald E. Weishaar, et al., Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets, Biochemical Pharmacology, vol. 35, No. 5., pp. 787-800, 1986.
G.T. Rogers and T.L.V. Ulbricht, Synthesis of 3-Methylisoguanine (6-amino-3-methylpurin-2(3H)-one), J. Chem. Soc. (C), pp. 2364-2366, 1971.
Chemical Abstracts 116:173873 (1979) Girshovich.
J. A. Montgomery, et al., "Synthesis of Potential Anticancer Agents. XIX. 2-Substituted N.sup.6 -Alkyladenines" (1959) J.A.C.S. vol 81, pp. 3963-3967.
Chemical Abstracts 53:6243, (1957) Elion.
T. Fuji, et al. "3-Substituted Adenines. In Vitro Enzyme Inhibition and Antiviral Activity", (1979) Journal of Medicinal Chemistry, vol. 22, No. 2, pp. 126-129.
Burger, Ed. "Medicinal Chemistry" 2d ed. pp. 42-43, Interscience, New York, New York (1960).
Derwent Abstract of JP 1200246, published Aug. 11, 1989.
Derwent Abstract of JP 1245256, published Sep. 29, 1989.
Derwent Abstract of JP 1231049, published Sep. 14, 1989.
Derwent Abstract of JP 1229251, published Sep. 12, 1989.
Derwent Abstract of JP 1225951, published Sep. 8, 1989.
Derwent Abstract of JP 1224756, published Sep. 7, 1989.
Derwent Abstract of JP 1224755, published Sep. 7, 1989.
Derwent Abstract of JP 1219748, published Sep. 1, 1989.
Derwent Abstract of JP 1216353, published Aug. 20, 1989.
Derwent Abstract of JP 1214845, published Aug. 29, 1989.
Derwent Abstract of JP 1093733, published Apr. 12, 1989.
Derwent Abstract of JP 63271246, published Nov. 9, 1988.
Derwent Abstract of JP 58111034, published Jul. 1, 1983.
Derwent Abstract of DE 144519 (1964).
CA Select: "Anti-Inflammatory Agents & Arthritis" Issue 7, 1996, p. 26,
Cavalla David John
Chasin Mark
Dolby Lloyd J.
Frith Richard William
Dees Jos,e G.
Euro-Celtique S.A.
Stockton Laura L.
LandOfFree
Aryl pyrazole compound for inhibiting phosphodiesterase IV and m does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl pyrazole compound for inhibiting phosphodiesterase IV and m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl pyrazole compound for inhibiting phosphodiesterase IV and m will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2276055